Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
4
Mins
12th November 2015
Sherlock Holmes and the Assessment of Premature MI
At the 2015 ESC congress in London UK, Aegerion Pharmaceuticals organized a satellite symposium in which three expert witnesses were cross examined on…
12th November 2015
Intelligent Application of Breast Cancer Trials Data in the Clinic
This meeting commenced with a talk from Prof Loibl on neoadjuvant and adjuvant strategies for HER2positive (human epidermal growth factor receptor…)
12th November 2015
Incorporating PARP Inhibition in Cancer Therapy: Key Questions, Expert Answers
This engaging symposium focussed on the rationale and current evidence supporting the role for poly(adenosine diphosphate-ribose) polymerase (PARP)…
12th November 2015
Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma: Results of a Randomised Phase III Trial (METEOR)
The METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma (RCC) was reported by Prof Choueiri at the European Cancer Congress…
12th November 2015
Current and Future Developments in the Treatment of CD30+ Lymphomas
CD30 is a cell membrane protein expressed on the surface of a range of lymphomas, which has important diagnostic, pathogenic, and prognostic roles.
2
Mins
11th November 2015
RapidPlan Knowledge-Based Radiotherapy Treatment Planning
Earlier this year, a 76-year-old man with prostate cancer became the first radiotherapy patient in the world whose treatment was planned using…
3rd November 2015
Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients?
This symposium aimed to address the current issues in the management of patients with Type 2 diabetes (T2D) post-acute coronary syndrome (ACS), bringing…
3rd November 2015
Why Are Incretin-Based Therapies More Efficient in East Asians? Perspectives from the Pathophysiology of Type 2 Diabetes and East Asian Dietary Habits
Type 2 diabetes mellitus (T2D) is one of the most serious global health problems. This is partly a result of its drastic increase in East Asia…
3rd November 2015
Benefits of Bariatric Surgery and Perioperative Surgical Safety
Obesity is a worldwide problem with numerous associated health problems. The number of patients eligible for surgery outnumber surgical capacity…
3rd November 2015
Moderate Hypoxia Exposure: A Novel Strategy to Improve Glucose Metabolism in Humans?
The obesity epidemic calls for novel strategies to prevent and treat obesity and its comorbidities. Several studies have indicated that…
←
1
2
3
…
781
782
783
784
785
786
787
…
865
866
867
→